Neuralgia Treatment Market Size

Neuralgia TreatmentMarket Size

The global neuralgia treatment market size was valued at USD 2.4 billion in 2024 and is expected to exhibit growth at a CAGR of 7.7% from 2025 to 2034 period. The market growth is attributed to the rising prevalence of neurological disorders and increase in awareness and diagnosis rates, contributing to their growing adoption.

To get key market trends

  Download Free Sample

Neurological disorders, including trigeminal neuralgia, postherpetic neuralgia, and diabetic neuropathy, are on the rise, driving growth in the market. A key contributor is the aging global population, with older adults being more vulnerable to neuropathic pain and its complications. According to the National Institute of Neurological Disorders and Stroke (NINDS), approximately 20 million people in the U.S. alone suffer from some form of peripheral neuropathy, highlighting the growing burden of neurological disorders. Moreover, shifts in lifestyle and an increasing prevalence of chronic diseases, notably diabetes, are amplifying the incidence of neuralgia.
 

Neuralgia treatment involves medical interventions aimed at alleviating pain caused by nerve damage or irritation, typically associated with conditions like trigeminal neuralgia, postherpetic neuralgia, and occipital neuralgia. Treatment options include medications, minimally invasive surgical procedures, and lifestyle modifications to manage symptoms effectively.